Recently, an outbreak of hantavirus on the cruise ship "Hondius" has brought renewed attention to efforts aimed at developing a vaccine against the virus. Experts say that hantavirus vaccine development has repeatedly stalled, partly because outbreaks are sporadic and irregular, primarily affecting poorer countries where pharmaceutical companies are less inclined to invest. Without strong government support, a hantavirus vaccine may not enter clinical trials for ten years or even longer.
Image source: internet
Cruise Ship Now Affected by Hantavirus
Original article: toutiao.com/article/1864689110236233/
Disclaimer: This article represents the personal views of the author